Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Dec 10, 2021- Dividend increased by 4.4%; follows a 25% increase in 2021- Board of directors also has authorized a new share repurchase program- Reflects Abbott's longstanding commitment to sustainable growth and shareholder returns
- Oct 20, 2021- Third-quarter sales growth of 23.4 percent; organic sales growth of 22.4 percent- GAAP diluted EPS from continuing operations growth of 69.6 percent; adjusted diluted EPS growth of 42.9 percent- Global COVID-19 testing-related sales were $1.9 billion in the third quarter- Excluding COVID-19 testing-related sales, third-quarter sales grew 11.7 percent on both a reported and organic basis compared to sales in 2019- Continues to strengthen portfolio with several new product approvals
- Jul 22, 2021- Sales growth of 39.5 percent; organic sales growth of 35.0 percent- GAAP diluted EPS from continuing operations growth of 120.0 percent; adjusted diluted EPS growth of 105.3 percent- Second-quarter sales, excluding COVID-19 testing-related sales, grew 12.3 percent on a reported basis and 11.3 percent on an organic basis compared to sales in 2019- Achieved strong sales growth across all four major business areas- Full-year forecast continues to reflect strong, double-digit EPS growth on both a GAAP and adjusted basis
- Jun 1, 2021- Updated outlook reflects lower recent and projected demand for COVID-19 tests- Revised forecast continues to reflect strong, double-digit EPS growth on both a GAAP and adjusted basis- Abbott's base business, excluding COVID-19 testing-related sales, continues to achieve strong growth- R&D pipeline continues to be highly productive, with a steady cadence of recent and upcoming product launches across the portfolio
- Apr 20, 2021- Sales growth of 35.3 percent; organic sales growth of 32.9 percent- GAAP diluted EPS growth from continuing operations of 233.3 percent; adjusted diluted EPS growth of 103.1 percent- All four major businesses achieved strong sales growth in the quarter- Projected full-year EPS remains unchanged; reflects growth of more than 35 percent